Annovation won backing from healthcare company The Medicines Company and venture investors including Atlas Venture.
Biopharmaceutical firm Annovation Biopharma has raised $8m in its series A round, led by Atlas Venture with participation from Partners Innovation Fund (PIF) and new investor healthcare company The Medicines Company.
US-based Annovation has now raised $10m in total venture funding. In a venture round during July, the firm secured a $2m investment from Atlas Venture.
As part of the deal, Jean-Francois Formela, managing director from Atlas Venture, Carl Berke from PIF and Jason Campagna from The Medicines Company will…
